Shares of Apotex Health Corp. rose during their first morning of trading, a sign of solid investor support for the drug manufacturer’s billion-dollar initial public offering. Apotex initially set out to raise $1-billion and hoped to price its shares between $20 and $24 apiece, but the Toronto-based …